Monday, April 17, 2023: M&A

Merck & Co. will buy Prometheus Biosciences Inc. for about $10.8 billion to bolster its research pipeline and strengthen its portfolio of autoimmune drugs. The agreement to buy the biotech company, one of the largest pharma deals in recent history, comes as...